| scholarly article | Q13442814 |
| P50 | author | Victor Trevino | Q41044719 |
| Kosuke Yoshihara | Q51394156 | ||
| Hoon Kim | Q59545155 | ||
| P2093 | author name string | E Martínez | |
| G M Mills | |||
| R G W Verhaak | |||
| P2860 | cites work | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms | Q24339394 |
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| The Reactome pathway knowledgebase | Q24567743 | ||
| Data, information, knowledge and principle: back to metabolism in KEGG | Q24568332 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | Q24633070 | ||
| Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| PID: the Pathway Interaction Database | Q24656193 | ||
| Nivolumab plus ipilimumab in advanced melanoma | Q27852310 | ||
| Comprehensive molecular characterization of clear cell renal cell carcinoma | Q27852374 | ||
| Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
| Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma | Q27860650 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Comprehensive genomic characterization of squamous cell lung cancers | Q28274701 | ||
| Integrated genomic characterization of endometrial carcinoma | Q28289962 | ||
| Temporal regulation of EGF signalling networks by the scaffold protein Shc1 | Q28294401 | ||
| The somatic genomic landscape of glioblastoma | Q28300185 | ||
| Comprehensive molecular characterization of urothelial bladder carcinoma | Q28306864 | ||
| Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells | Q28585746 | ||
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| Diagnosis of multiple cancer types by shrunken centroids of gene expression | Q29615528 | ||
| Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia | Q29615735 | ||
| Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses | Q29616071 | ||
| Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 | Q29617043 | ||
| Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 | ||
| Inferring tumour purity and stromal and immune cell admixture from expression data | Q30674996 | ||
| Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. | Q33597322 | ||
| Absolute quantification of somatic DNA alterations in human cancer | Q34271693 | ||
| Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. | Q34602664 | ||
| Emerging landscape of oncogenic signatures across human cancers | Q35058708 | ||
| Subtype and pathway specific responses to anticancer compounds in breast cancer | Q35779241 | ||
| Prognostically relevant gene signatures of high-grade serous ovarian carcinoma | Q36497294 | ||
| What is a support vector machine? | Q36679246 | ||
| A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival | Q37019200 | ||
| Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling | Q37059396 | ||
| Metagenes and molecular pattern discovery using matrix factorization | Q37356699 | ||
| Pan-cancer patterns of somatic copy number alteration | Q37666205 | ||
| Prognostically useful gene-expression profiles in acute myeloid leukemia. | Q51999490 | ||
| Cluster Analysis | Q57585102 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2732-2740 | |
| P577 | publication date | 2014-08-04 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects | |
| P478 | volume | 34 |
| Q55437282 | AUCTSP: an improved biomarker gene pair class predictor. |
| Q55287292 | Double agents: genes with both oncogenic and tumor-suppressor functions. |
| Q37174032 | Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer |
| Q45870735 | Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas |
| Q41557019 | Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm |
| Q36848243 | Immunomediated Pan-cancer Regulation Networks are Dominant Fingerprints After Treatment of Cell Lines with Demethylation. |
| Q35899607 | Informative gene selection and the direct classification of tumors based on relative simplicity |
| Q34123261 | Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin |
| Q92692775 | NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods |
| Q47547178 | Network analysis revealed aurora kinase dysregulation in five gynecological types of cancer |
| Q58097633 | Network integration of multi-tumour omics data suggests novel targeting strategies |
| Q47193672 | Optimizing prognosis-related key miRNA-target interactions responsible for cancer metastasis |
| Q36830260 | Pan-cancer subtyping in a 2D-map shows substructures that are driven by specific combinations of molecular characteristics |
| Q41243664 | Pan-urologic cancer genomic subtypes that transcend tissue of origin |
| Q35838819 | Profiling of Discrete Gynecological Cancers Reveals Novel Transcriptional Modules and Common Features Shared by Other Cancer Types and Embryonic Stem Cells |
| Q86068877 | Pseudogene: promising signature for cancer reclassification : comment on "The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes", Nat Commun. 2014; 5:3963 |
| Q55315462 | Sorting Five Human Tumor Types Reveals Specific Biomarkers and Background Classification Genes. |
| Q41521817 | Systematic analysis of telomere length and somatic alterations in 31 cancer types. |
| Q36350773 | Systematic pan-cancer analysis of tumour purity |
| Q31103785 | TP53 Mutations and Survival in Osteosarcoma Patients: A Meta-Analysis of Published Data |
| Q64101370 | The landscape of the mesenchymal signature in brain tumours |
| Q41092592 | Transcriptional response profiles of paired tumor-normal samples offer novel perspectives in pan-cancer analysis |
| Q46410671 | Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. |
Search more.